{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:01Z","timestamp":1786991221935,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007698","name":"University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jacc.2024.08.051","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T10:03:47Z","timestamp":1729505027000},"page":"1721-1729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Platelet Fc\u03b3RIIa as a Marker of Cardiovascular Risk After Myocardial\u00a0Infarction"],"prefix":"10.1016","volume":"84","author":[{"given":"David J.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Fanaroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homam","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Hohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Wanamaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark B.","family":"Effron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"DiBattiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2024.08.051_bib1","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.08.051_bib2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.08.051_bib3","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.08.051_bib4","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1016\/j.jacc.2024.08.051_bib5","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"Amsterdam","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.08.051_bib6","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1161\/CIRCULATIONAHA.123.064473","article-title":"Defining strategies of modulation of antiplatelet therapy in patients with coronary artery disease: a consensus document from the academic research consortium","volume":"147","author":"Capodanno","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.08.051_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","article-title":"Comparison of clopidogrel monotherapy after 1 to 2\u00a0months of dual antiplatelet therapy with 12\u00a0months of dual antiplatelet therapy in patients with acute coronary syndrome: the STOPDAPT-2 ACS randomized clinical trial","volume":"7","author":"Watanabe","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2024.08.051_bib8","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41569-023-00901-2","article-title":"De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a consensus statement from an international expert panel on coronary thrombosis","volume":"20","author":"Gorog","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jacc.2024.08.051_bib9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1182\/blood.V60.6.1277.1277","article-title":"Characterization of the IgG-Fc receptor on human platelets","volume":"60","author":"Karas","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2024.08.051_bib10","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1182\/blood-2008-02-142125","article-title":"Identification of Fc\u03b3RIIa as the ITAM-bearing receptor mediating \u03b1IIb\u03b23 outside-in integrin signaling in human platelets","volume":"112","author":"Boylan","year":"2008","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.jacc.2024.08.051_bib11","doi-asserted-by":"crossref","first-page":"12009","DOI":"10.1074\/jbc.M111803200","article-title":"A\u00a0Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets","volume":"277","author":"Lova","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jacc.2024.08.051_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-9560-5-7","article-title":"Increased platelet expression of Fc\u03b3RIIa and its potential impact on platelet reactivity in patients with end stage renal disease","volume":"5","author":"Serrano","year":"2007","journal-title":"Thromb J"},{"key":"10.1016\/j.jacc.2024.08.051_bib13","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/blood-2012-07-443325","article-title":"Cooperative integrin\/ITAM signaling in platelets enhances thrombus formation in\u00a0vitro and in\u00a0vivo","volume":"121","author":"Zhi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jacc.2024.08.051_bib14","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacc.2018.04.046","article-title":"Fc\u03b3RIIa: a new cardiovascular risk marker","volume":"72","author":"Schneider","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.08.051_bib15","first-page":"1175","article-title":"Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction","volume":"105","author":"Lindholm","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2024.08.051_bib16","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2024.08.051_bib17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.jacc.2024.08.051_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jth.12538","article-title":"Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis","volume":"12","author":"Wisman","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jacc.2024.08.051_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0021-9150(02)00179-X","article-title":"Potential role of platelet Fc\u03b3RIIA in collagen-mediated platelet activation associated with atherothrombosis","volume":"164","author":"Calverley","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2024.08.051_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2141.2003.04233.x","article-title":"Increased platelet Fc receptor expression as a potential contributing cause of platelet hypersensitivity to collagen in diabetes mellitus","volume":"121","author":"Calverley","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jacc.2024.08.051_bib21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/ATVBAHA.109.187567","article-title":"Augmentation of megakaryocyte expression of Fc\u03b3RIIa by interferon \u03b3","volume":"29","author":"Schneider","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacc.2024.08.051_bib22","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2024.08.051_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00011-005-1377-2","article-title":"Gamma interferon: a central mediator in atherosclerosis","volume":"54","author":"Leon","year":"2005","journal-title":"Inflamm Res"},{"key":"10.1016\/j.jacc.2024.08.051_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","article-title":"Inhibition of progression and stabilization of plaques by postnatal interferon-\u03b3 function blocking in ApoE-knockout mice","volume":"101","author":"Koga","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jacc.2024.08.051_bib25","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0735-1097(01)01660-6","article-title":"Increased production of inflammatory cytokines in patients with silent myocardial ischemia","volume":"38","author":"Mazzone","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2024.08.051_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s11892-007-0038-y","article-title":"Inflammatory mechanisms of diabetic complications","volume":"7","author":"Williams","year":"2007","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jacc.2024.08.051_bib27","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/j.2040-4603.2013.tb00511.x","article-title":"Immune and inflammatory role in renal disease","volume":"3","author":"Imig","year":"2013","journal-title":"Compr Physiol"},{"key":"10.1016\/j.jacc.2024.08.051_bib28","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.amjcard.2019.12.008","article-title":"Assessment of cardiovascular risk by the combination of clinical risk scores plus platelet expression of Fc\u03b3RIIa","volume":"125","author":"Schneider","year":"2020","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jacc.2024.08.051_bib29","article-title":"Relationship of platelet reactivity with bleeding outcomes during long-term treatment with dual antiplatelet therapy for medically managed patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"4","author":"Cornel","year":"2016","journal-title":"J\u00a0Am Heart Assoc"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724083153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109724083153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:37:44Z","timestamp":1761784664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109724083153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":29,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0735109724083153"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2024.08.051","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet Fc\u03b3RIIa as a Marker of Cardiovascular Risk After Myocardial\u00a0Infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2024.08.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}